News and Trends 24 Jan 2023CytoReason expands deal with Sanofi to look at IBD CytoReason, which creates computational disease modeling, has announced an expansion of its collaboration with Sanofi. The multi-year collaboration will further… January 24, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 20 Sep 2022CytoReason and Pfizer agree deal worth up to $110M for AI drug discovery and development In a deal with a potential value of $110 million over the next five years, CytoReason has announced an extension… September 20, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email